FreeIn Brief Fisher named executive director, research, business administration at Siteman April 06, 2018Vol.44 No.14
Conversation with The Cancer LetterFree Manocherian: We have been unapologetic in advocating for 10% annual increases to NIH April 06, 2018Vol.44 No.14By Matthew Bin Han Ong
Free How Jed Manocherian’s stealth campaign for NIH was outed by its own success April 06, 2018Vol.44 No.14By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Porter: I can’t tell you how the Trump administration gets its budget numbers March 16, 2018Vol.44 No.11By Paul Goldberg
Clinical RoundupFree Roswell Park ovarian cancer registry data links ovarian and testicular cancer March 09, 2018Vol.44 No.10
Conversation with The Cancer LetterFree BMS’s Farajallah: Opdivo is the only PD-1 inhibitor approved for four-week dosing March 09, 2018Vol.44 No.10By Matthew Bin Han Ong
